Chromodynamics has secured €2 million from KIKK Capital to enhance product development and marketing for its innovative Tesseract technology in the pharmaceutical sector.

Information on the Target

Chromodynamics, founded and based in Eindhoven, focuses on eliminating uncertainty in the field of drug development and prescription through innovative technology. The company's flagship product, the Tesseract, empowers clients by providing high-quality spectral data from every pixel of an image, ensuring uncompromised resolution and measurement speed.

With this groundbreaking approach, Chromodynamics aims to streamline the drug development process, enhancing accuracy and efficiency for pharmaceutical companies and researchers alike.

Industry Overview in the Netherlands

The Netherlands boasts a robust pharmaceutical industry, characterized by substantial investment in research and development. The country